The immune response in multiple sclerosis

S Rodríguez Murúa, MF Farez… - Annual Review of …, 2022 - annualreviews.org
Multiple sclerosis (MS) is a chronic autoimmune, inflammatory, and neurodegenerative
disease that affects the central nervous system (CNS). MS is characterized by immune …

An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis

N Garg, TW Smith - Brain and behavior, 2015 - Wiley Online Library
Background Multiple sclerosis is an acquired demyelinating disease of the central nervous
system. It is the second most common cause of disability in adults in United States after head …

A comprehensive analysis of the role of hnRNP A1 function and dysfunction in the pathogenesis of neurodegenerative disease

JP Clarke, PA Thibault, HE Salapa… - Frontiers in molecular …, 2021 - frontiersin.org
Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) is a member of the hnRNP family
of conserved proteins that is involved in RNA transcription, pre-mRNA splicing, mRNA …

The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets

R Hohlfeld, K Dornmair, E Meinl, H Wekerle - The Lancet Neurology, 2016 - thelancet.com
Identification of the target antigens of pathogenic antibodies and T cells is of fundamental
importance for understanding the pathogenesis of multiple sclerosis, and for the …

Immunology of multiple sclerosis

M Sospedra, R Martin - Seminars in neurology, 2016 - thieme-connect.com
Multiple sclerosis (MS) is considered a prototypic autoimmune disease of the central
nervous system (CNS). A complex genetic background with the HLA-DR15 haplotype as the …

Autoimmunity due to molecular mimicry as a cause of neurological disease

MC Levin, SM Lee, F Kalume, Y Morcos, FC Dohan Jr… - Nature medicine, 2002 - nature.com
One hypothesis that couples infection with autoimmune disease is molecular mimicry.
Molecular mimicry is characterized by an immune response to an environmental agent that …

Mechanisms of action of glatiramer acetate in multiple sclerosis

O Neuhaus, C Farina, H Wekerle, R Hohlfeld - Neurology, 2001 - AAN Enterprises
Glatiramer acetate (GA, Copaxone [Teva Pharmaceuticals, Kansas City, MO], formerly
known as copolymer-1) and interferon-(IFN)-β are both used for the immunomodulatory …

Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines

R Hohlfeld, H Wekerle - Proceedings of the National …, 2004 - National Acad Sciences
Autoimmune T and B cell responses to CNS antigen (s) are thought to drive the
pathogenesis of multiple sclerosis (MS), and thus are logical targets for therapy. Indeed …

The role of B cells and autoantibodies in multiple sclerosis

JJ Archelos, MK Storch… - Annals of Neurology …, 2000 - Wiley Online Library
A variety of cellular and humoral immunological abnormalities have been observed in
multiple sclerosis (MS). In the past few years, several lines of evidence converged to imply …

The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis

KC O'connor, A Bar-Or, DA Hafler - Journal of clinical immunology, 2001 - Springer
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system white
matter. The association of the disease with MHC genes, the inflammatory white matter …